Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Penn State Hershey Medical Center, Hershey, Pennsylvania, United States
Golden Jubilee National Hospital, Clydebank, United Kingdom
Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States
Chang Gung Memorial Hospital, Taipei, Taiwan
Ruijin Hospital, Shanghai, Shanghai, China
University Hospital Zurich, Zurich, Switzerland
Tampere University Hospital, Tampere, Finland
Hospital San Pedro de Alcantara, Caceres, Spain
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.